Daniel Tottleben
Dinaqor ag is an excellent company. Their products are of high quality and they offer great customer service. I highly recommend them!
Patrick Kirchen
I absolutely love Dinaqor ag's products! They have helped me improve my health and well-being. The customer service is exceptional, always ready to assist. Highly recommend!
Becky Williams
🌟🌟🌟🌟🌟 The quality of Dinaqor ag's products is amazing! The customer service is also very friendly and helpful. I am extremely happy with my purchase.
Paul Gaul
I recently purchased some products from a company website. The product quality was really good and the customer service was top-notch. I am very satisfied with my purchase.
Scott D'Amato
👍 I just started using Dinaqor ag's products and I am already impressed with the results. Their products are effective and the customer service is helpful. Highly recommended!
Tammy Campbell
I have been a loyal customer of Dinaqor ag for a while now and they have never disappointed me. Their products are of great quality and the customer service is outstanding. Highly recommended!
Rohit Chandramohanan
The experience with the company website was really smooth. I received my order on time and the products were of great quality. I would definitely purchase from them again.
Nicola Blue
Recently tried out some new products - really impressed with the quality. The customer service was also very helpful, answering all my questions promptly. Will definitely be a repeat customer!
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Dinaqor ag
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure. Its lead preclinical program, DiNA-001, is focused on the treatment of MYBPC3-linked cardiomyopathy. DiNAQOR was founded in 2019 and is headquartered in Pfäffikon, Switzerland.
- Website
- dinaqor.com
- Categories
- Biotechnology